[14] In vitro immunoglobulin light chain fibrillogenesis
Authors:
- Jonathan WallJonathan Wall
- Charles L. MurphyCMCharles L. Murphy
- Alan SolomonASAlan Solomon
- 1 January 1999
- book chapter
- Published by Elsevier
- Vol. 309, 204-217
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Amino-terminal identity of co-existent amyloid and non-amyloid immunoglobulin κ light chain deposits. A human disease to study alterations of protein conformationClinical and Experimental Immunology, 1997
- Domain Stability in Immunoglobulin Light Chain Deposition Disorders1997
- Specificity of Abnormal Assembly in Immunoglobulin Light Chain Deposition Disease and AmyloidosisJournal of Molecular Biology, 1996
- Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light‐chain amyloid proteinsProtein Science, 1995
- AmyloidosisCritical Reviews in Clinical Laboratory Sciences, 1994
- Nephrotoxic Potential of Bence Jones ProteinsNew England Journal of Medicine, 1991
- [6] Quantitation of protein1990
- Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine TAnalytical Biochemistry, 1989
- Methods for Staining Amyloid in Tissues: A ReviewStain Technology, 1988
- Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathwayBiophysical Journal, 1984